デフォルト表紙
市場調査レポート
商品コード
1593488

ビタミンD検査の世界市場規模、シェア、成長分析:製品別、症状別、技術別、患者別、検査場所別、最終用途別、地域別 - 産業予測(2024年~2031年)

Vitamin D Testing Market Size, Share, Growth Analysis, By Product (25-Hydroxy Vitamin D Test, 1,25-Dihydroxy Vitamin D Test), By Indication (Osteoporosis, Rickets), By Technology, By Test Location, By End Use, By Region - Industry Forecast 2024-2031


出版日
発行
SkyQuest
ページ情報
英文 154 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
ビタミンD検査の世界市場規模、シェア、成長分析:製品別、症状別、技術別、患者別、検査場所別、最終用途別、地域別 - 産業予測(2024年~2031年)
出版日: 2024年11月13日
発行: SkyQuest
ページ情報: 英文 154 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のビタミンD検査の市場規模は、2022年に8億4,882万米ドルと評価され、2023年の9億2,131万米ドルから2031年には17億7,470万米ドルに成長し、予測期間(2024年~2031年)のCAGRは8.54%で成長する見通しです。

ビタミンD検査市場は、ビタミンD濃度を評価する診断検査が、免疫の健康や全身の健康に影響を及ぼす可能性のあるビタミンDの欠乏や過剰を特定する上で重要な役割を果たすことから、牽引力を増しています。ビタミンDが健康に及ぼす影響に対する意識の高まりが検査需要に拍車をかけ、より迅速で正確な結果を提供する検査法の革新がそれを補完しています。この動向は、予防ヘルスケアや定期的な健康診断に向けた幅広い動きと一致しており、市場の成長をさらに後押ししています。しかし課題も残っており、特に液体クロマトグラフィータンデム質量分析のような高度な検査技術に関連するコストは高く、中低所得地域では利用が制限される可能性があります。さらに、特定の未開拓地域における認知度の低さが市場拡大の妨げとなっています。このような障害にもかかわらず、検査技術の継続的な向上と個別化された健康・ウェルネスソリューションの進歩により、情勢は有望な機会を秘めています。市場が発展するにつれて、利害関係者は価格設定の障壁や地域格差を乗り越えながら、認知度の向上と技術的改善を活用して、ビタミンD検査のリーチと効果を最適化する必要があります。

目次

イントロダクション

  • 調査の目的
  • 定義
  • 市場範囲

調査手法

  • 情報調達
  • 二次・一次情報源
  • 市場規模予測
  • 市場の想定と制限

エグゼクティブサマリー

  • 市場概要見通し
  • 供給需要動向分析
  • セグメント別の機会分析

市場力学と見通し

  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
  • ポーターの分析

主な市場の考察

  • 技術分析
  • バリューチェーン分析
  • 市場のエコシステム
  • 特許分析
  • 規制情勢
  • イノベーションマトリクス
  • 主な投資の分析
  • 主な成功要因
  • 競合の程度

ビタミンD検査市場:製品別

  • 市場概要
  • 25-ヒドロキシビタミンD検査
  • 1,25-ジヒドロキシビタミンD検査

ビタミンD検査市場:症状別

  • 市場概要
  • 骨粗鬆症
  • くる病
  • 甲状腺疾患
  • ビタミンD欠乏症
  • その他

ビタミンD検査市場:技術別

  • 市場概要
  • 放射免疫測定
  • ELISA
  • HPLC
  • LC-MS
  • その他

ビタミンD検査市場:患者別

  • 市場概要
  • 大人
  • 小児

ビタミンD検査市場:検査場所別

  • 市場概要
  • ポイントオブケア
  • その他

ビタミンD検査市場:最終用途別

  • 市場概要
  • 病院
  • 診断検査室
  • 在宅ケア
  • その他

ビタミンD検査市場:地域別

  • 市場概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ
  • 中東・アフリカ(MEA)
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主な市場企業が採用した戦略
  • 市場における最近の活動
  • 主要企業の市場シェア(2023年)

主要企業プロファイル

  • Abbott
  • Danaher
  • F. Hoffmann-La Roche Ltd
  • Siemens AG
  • Quest Diagnostics Incorporated.
  • BIOMERIEUX
  • DiaSorin S.p.A.
  • Thermo Fisher Scientific Inc.
  • SpectraCell Laboratories, Inc.
  • Tosoh Bioscience, Inc.
  • Bio-Rad Laboratories, Inc.
  • QuidedlOrtho
  • PerkinElmer, Inc.
  • Diazyme Laboratories, Inc.
  • Mindray Medical International Ltd.
  • DRG International, Inc.
  • Randox Laboratories Ltd.
  • Immunodiagnostic Systems Holdings
  • Revvity, Inc.
  • LabCorp
目次
Product Code: SQMIG35B2215

Global Vitamin D Testing Market size was valued at USD 848.82 million in 2022 and is poised to grow from USD 921.31 million in 2023 to USD 1774.70 million by 2031, growing at a CAGR of 8.54% during the forecast period (2024-2031).

The vitamin D testing market is gaining traction as diagnostic tests that assess vitamin D levels play a vital role in identifying deficiencies or excesses that can influence immune health and overall well-being. Growing awareness of the health implications tied to vitamin D has spurred demand for testing, complemented by innovations in testing methods that offer faster and more accurate results. This trend aligns with the broader movement towards preventive healthcare and routine health check-ups, further propelling market growth. However, challenges remain, particularly the high costs associated with advanced testing technologies like liquid chromatography-tandem mass spectrometry, which can restrict accessibility in low and middle-income regions. Additionally, low awareness in certain unexplored areas hinders market expansion. Despite these obstacles, the landscape holds promising opportunities through the continuous development of enhanced testing techniques and the advancement of personalized health and wellness solutions. As the market evolves, stakeholders must navigate pricing barriers and regional disparities while capitalizing on the increasing awareness and technological improvements to optimize the reach and effectiveness of vitamin D testing.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Vitamin D Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Vitamin D Testing Market Segmental Analysis

Global Vitamin D Testing Market is segmented by Product, Indication, Technology, Patient, Test Location, End Use, and Region. Based on Product, the market is segmented into 25-Hydroxy Vitamin D Test, 1,25-Dihydroxy Vitamin D Test. Based on Indication, the market is segmented into Osteoporosis, Rickets, Thyroid Disorders, Vitamin D Deficiency, Others. Based on Technology, the market is segmented into Radioimmunoassay, ELISA, HPLC, LC-MS, Others. Based on Patient, the market is segmented into Adult, Pediatric. Based on Test Location, the market is segmented into Point-of-Care, Others. Based on End Use, the market is segmented into Hospitals, Diagnostic Laboratories, Homecare, Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Vitamin D Testing Market

The rise in preventive healthcare is a significant market driver for the Global Vitamin D Testing market. As individuals increasingly prioritize health and wellness, there is a growing recognition of the critical role vitamin D plays in overall health, immune function, and disease prevention. This shift towards preventive measures has led to heightened awareness and demand for vitamin D testing, enabling early detection of deficiencies that can lead to serious health complications. Additionally, healthcare providers are incorporating vitamin D assessments in routine screenings, further driving market growth as consumers seek proactive measures to maintain optimal health and well-being.

Restraints in the Global Vitamin D Testing Market

One of the primary market restraints for the global vitamin D testing market is the inconsistency of test results across different diagnostic platforms and methodologies. Variations in assay techniques, sample handling, and laboratory protocols can lead to discrepancies and unreliable readings, which may undermine clinician trust and patient compliance. This inconsistency is compounded by the lack of standardization in vitamin D testing practices, making it challenging for healthcare providers to assess patient vitamin D levels accurately. Such uncertainties can hinder market growth as laboratories and healthcare facilities may be hesitant to adopt or invest in vitamin D testing solutions due to concerns over their reliability.

Market Trends of the Global Vitamin D Testing Market

The Global Vitamin D Testing market is increasingly characterized by the rapid progress of home testing kits, reflecting a significant shift towards privacy and convenience in healthcare. Consumers are opting for these user-friendly kits, which utilize a simple finger-prick blood specimen, eliminating the need for frequent hospital visits. This trend is bolstered by companies offering direct-to-consumer solutions that allow users to easily order and send their samples to labs for analysis. The growing awareness of vitamin D's health benefits, coupled with the rising trend of personalized healthcare, positions home testing as a vital component of the evolving vitamin D testing landscape, driving market growth.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Technology Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • Patent Analysis
  • Regulatory Landscape
  • Innovation Matrix
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition

Vitamin D Testing Market by Product

  • Market Overview
  • 25-Hydroxy Vitamin D Test
  • 1,25-Dihydroxy Vitamin D Test

Vitamin D Testing Market by Indication

  • Market Overview
  • Osteoporosis
  • Rickets
  • Thyroid Disorders
  • Vitamin D Deficiency
  • Others

Vitamin D Testing Market by Technology

  • Market Overview
  • Radioimmunoassay
  • ELISA
  • HPLC
  • LC-MS
  • Others

Vitamin D Testing Market by Patient

  • Market Overview
  • Adult
  • Pediatric

Vitamin D Testing Market by Test Location

  • Market Overview
  • Point-of-Care
  • Others

Vitamin D Testing Market by End Use

  • Market Overview
  • Hospitals
  • Diagnostic Laboratories
  • Homecare
  • Others

Vitamin D Testing Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Abbott
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danaher
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • F. Hoffmann-La Roche Ltd
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens AG
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Quest Diagnostics Incorporated.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BIOMERIEUX
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DiaSorin S.p.A.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SpectraCell Laboratories, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Tosoh Bioscience, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bio-Rad Laboratories, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • QuidedlOrtho
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • PerkinElmer, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Diazyme Laboratories, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mindray Medical International Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DRG International, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Randox Laboratories Ltd.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Immunodiagnostic Systems Holdings
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Revvity, Inc.
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LabCorp
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments